Evidence map›Paper›PMID 36528760›Full record

ArticleActa neuropathologica communications2022

NEB mutations disrupt the super-relaxed state of myosin and remodel the muscle metabolic proteome in nemaline myopathy.

Natasha Ranu, Jenni Laitila, Hannah F Dugdale, Jennifer Mariano, Justin S Kolb, Carina Wallgren-Pettersson, Nanna Witting, John Vissing, Juan Jesus Vilchez, Chiara Fiorillo and 13 more

Open access · goldAbstract read
In one paragraph

Article in Acta neuropathologica communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
6.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. The D2.B10-DmdThe American journal of pathology · 2026
    Article
  3. Article
  4. A homozygous single-nucleotide variant inJournal of neuromuscular diseases · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Predominant myosin superrelaxed state in canine myocardium with naturally occurring dilated cardiomyopathy.American journal of physiology. Heart and circulatory physiology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 16 institutions in 9 countries.

Natasha Ranu *Centre of Human and Applied Physiological Sciences, School of Basic and Medical Biosciences, Faculty of Life Sciences & Medicine, King's College London, London, UK.
Jenni Laitila *Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark.
Hannah F DugdaleCentre of Human and Applied Physiological Sciences, School of Basic and Medical Biosciences, Faculty of Life Sciences & Medicine, King's College London, London, UK.
Jennifer MarianoDepartment of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, USA.
Justin S KolbDepartment of Cellular and Molecular Medicine, University of Arizona, Tucson, USA.
Carina Wallgren-PetterssonThe Folkhälsan Institute of Genetics and Department of Medical and Clinical Genetics, Medicum, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland.
Nanna WittingCopenhagen Neuromuscular Center, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
John VissingCopenhagen Neuromuscular Center, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Juan Jesus VilchezNeuromuscular and Ataxias Research Group, Instituto de Investigación Sanitaria La Fe, Valencia, Spain.
Chiara FiorilloNeuromuscular Disorders Unit, IRCCS Istituto Giannina Gaslini, DINOGMI, University of Genoa, Genoa, Italy.
Edmar ZanoteliDepartment of Neurology, Faculdade de Medicina (FMUSP), Universidade de São Paulo, São Paulo, Brazil.
Mari AuranenClinical Neurosciences, University of Helsinki and Helsinki University Hospital, NeurologyHelsinki, Finland.
Manu JokelaNeurology, Clinical Medicine, University of Turku, Turku, Finland.
Giorgio TascaUnità Operativa Complessa di Neurologia, Fondazione Policlinico Universitario "A. Gemelli", IRCCS, Rome, Italy.
Kristl G ClaeysDepartment of Neurology, University Hospitals Leuven, Leuven, Belgium.
Nicol C VoermansDepartment of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.
Johanna PalmioNeuromuscular Research Center, Department of Neurology, Tampere University and University Hospital, Tampere, Finland.
Sanna HuovinenDepartment of Pathology, Fimlab Laboratories, Tampere University Hospital, Tampere, Finland.
Maurizio MoggioNeuromuscular and Rare Diseases Unit, Department of Neuroscience, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Thomas Nyegaard BeckDepartment of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark.
Aikaterini Kontrogianni-KonstantopoulosDepartment of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, USA.
Henk GranzierDepartment of Cellular and Molecular Medicine, University of Arizona, Tucson, USA.
Julien OchalaDepartment of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark. julien.ochala@sund.ku.dk.ORCID 0000-0002-6358-2920
University of Copenhagen · DKUniversity of Arizona · USUniversity of Helsinki · FIUniversity of Maryland, Baltimore · USCentre for Biomedical Network Research on Rare Diseases · ESFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico · ITIstituto Giannina Gaslini · ITKing's College London · GBKU Leuven · BELoughborough University · GBNewcastle upon Tyne Hospitals NHS Foundation Trust · GBRadboud University Nijmegen · NLTampere University · FITampere University Hospital · FIUniversidade de São Paulo · BRUniversity of Turku · FI

Funding

Interdisciplinary Training Program Muscle BiologyT32AR007592 · NIAMS · UNIVERSITY OF MARYLAND BALTIMORE · PI Aikaterini Kontrogianni-Konstantopoulos · 1996 to 2026
$11.7M
Novel MYBPC1 mutations cosegregate with a myopathy associated with muscle weakness, hypotonia and tremorR01AR076373 · NIAMS · UNIVERSITY OF MARYLAND BALTIMORE · PI KONTROGIANNI-KONSTANTOPOULOS, AIKATERINI · 2020 to 2024
$2.0M
NIAMS NIH HHS R01 AR076373NIAMS NIH HHS T32 AR007592
6 · The paper itself

Abstract

Nemaline myopathy (NM) is one of the most common non-dystrophic genetic muscle disorders. NM is often associated with mutations in the NEB gene. Even though the exact NEB-NM pathophysiological mechanisms remain unclear, histological analyses of patients' muscle biopsies often reveal unexplained accumulation of glycogen and abnormally shaped mitochondria. Hence, the aim of the present study was to define the exact molecular and cellular cascade of events that would lead to potential changes in muscle energetics in NEB-NM. For that, we applied a wide range of biophysical and cell biology assays on skeletal muscle fibres from NM patients as well as untargeted proteomics analyses on isolated myofibres from a muscle-specific nebulin-deficient mouse model. Unexpectedly, we found that the myosin stabilizing conformational state, known as super-relaxed state, was significantly impaired, inducing an increase in the energy (ATP) consumption of resting muscle fibres from NEB-NM patients when compared with controls or with other forms of genetic/rare, acquired NM. This destabilization of the myosin super-relaxed state had dynamic consequences as we observed a remodeling of the metabolic proteome in muscle fibres from nebulin-deficient mice. Altogether, our findings explain some of the hitherto obscure hallmarks of NM, including the appearance of abnormal energy proteins and suggest potential beneficial effects of drugs targeting myosin activity/conformations for NEB-NM.

Indexed as

Myopathies, NemalineAnimalsMiceMuscle Fibers, SkeletalMuscle ProteinsMuscle, SkeletalMutationMyosinsProteomeMuscle ProteinsMyosinsnebulinProteomeMetabolismMyosinNebulinNemaline myopathySkeletal muscle

Identifiers

PMID36528760
PMCPMC9758823
OpenAlexW4312065035

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.